Published in Carcinogenesis on November 01, 1995
Candidate gene case-control association studies: advantages and potential pitfalls. Br J Clin Pharmacol (2001) 1.24
Determination of cytochrome P450 2D6 (CYP2D6) gene copy number by real-time quantitative PCR. J Biomed Biotechnol (2005) 1.07
Genetic polymorphism of enzymes involved in xenobiotic metabolism and the risk of lung cancer. Environ Health Prev Med (2002) 0.81
Interaction between dose and susceptibility to environmental cancer: a short review. Environ Health Perspect (1997) 0.80
The sparteine/debrisoquine (CYP2D6) oxidation polymorphism and the risk of lung cancer: a meta-analysis. Eur J Clin Pharmacol (1997) 0.77
Molecular epidemiological study of non-small-cell lung cancer from an environmentally polluted region of Poland. Br J Cancer (1999) 0.75
Asbestos: scientific developments and implications for public policy. Science (1990) 7.06
Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. Hypertension (1995) 4.83
Has the impact of heat waves on mortality changed in France since the European heat wave of summer 2003? A study of the 2006 heat wave. Int J Epidemiol (2008) 3.82
Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer. J Clin Oncol (1999) 3.48
Mammalian microsomal cytochrome P450 monooxygenase: structural adaptations for membrane binding and functional diversity. Mol Cell (2000) 2.98
Optimization of initial tacrolimus dose using pharmacogenetic testing. Clin Pharmacol Ther (2010) 2.94
Assessing the significance of the correlation between two spatial processes. Biometrics (1989) 2.63
Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning. Int J Radiat Oncol Biol Phys (2000) 2.58
Pleural mesothelioma: dose-response relation at low levels of asbestos exposure in a French population-based case-control study. Am J Epidemiol (1998) 2.32
Review article: the benefits of pharmacogenetics for improving thiopurine therapy in inflammatory bowel disease. Aliment Pharmacol Ther (2011) 2.28
Epidemiological evidence on the carcinogenicity of silica: factors in scientific judgement. Ann Occup Hyg (2000) 2.27
Multivariate analysis of factors predictive of brain metastases in localised non-small cell lung carcinoma. Lung Cancer (2004) 2.22
A plasmocyte selective monoclonal antibody (B-B4) recognizes syndecan-1. Br J Haematol (1996) 2.21
Risk factors and clinical relevance of nosocomial maxillary sinusitis in the critically ill. Am J Respir Crit Care Med (1994) 2.19
Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy. Eur J Cancer (1993) 2.08
Accounting for pregnancy dependence in epidemiologic studies of reproductive outcomes. Epidemiology (1997) 2.07
Genetic factors (VKORC1, CYP2C9, EPHX1, and CYP4F2) are predictor variables for warfarin response in very elderly, frail inpatients. Clin Pharmacol Ther (2009) 2.04
Cytokine profiles in idiopathic pulmonary fibrosis suggest an important role for TGF-beta and IL-10. Eur Respir J (2003) 1.97
Comparison of relative risks obtained in ecological and individual studies: some methodological considerations. Int J Epidemiol (1987) 1.97
Mesotheliomas in rats following inoculation with acid-leached chrysotile asbestos and other mineral fibres. Carcinogenesis (1981) 1.94
The increase in urinary excretion of 6 beta-hydroxycortisol as a marker of human hepatic cytochrome P450IIIA induction. Br J Clin Pharmacol (1989) 1.92
Pleural effusion: laboratory tests in 300 cases. Thorax (1979) 1.85
Exogenous lipid pneumonia: a retrospective multicentre study of 44 cases in France. Eur Respir J (1996) 1.83
Molecular and serological diagnosis of Chikungunya virus infection. Pathol Biol (Paris) (2007) 1.83
Etoposide plus cisplatin with or without the combination of 4'-epidoxorubicin plus cyclophosphamide in treatment of extensive small-cell lung cancer: a French Federation of Cancer Institutes multicenter phase III randomized study. J Natl Cancer Inst (2001) 1.82
Zeolite bodies in human lungs from Turkey. Lab Invest (1981) 1.74
Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture. Mol Pharmacol (1993) 1.72
Immunocytochemical characterization of cell lines from human malignant mesothelioma: characterization of human mesothelioma cell lines by immunocytochemistry with a panel of monoclonal antibodies. Hum Pathol (1994) 1.70
Neutrophil alveolitis in bronchioloalveolar carcinoma: induction by tumor-derived interleukin-8 and relation to clinical outcome. Am J Pathol (1998) 1.66
Detection of plasma tumor DNA in head and neck squamous cell carcinoma by microsatellite typing and p53 mutation analysis. Cancer Res (2000) 1.63
Cloning and expression of a complementary DNA encoding a high affinity human neurotensin receptor. FEBS Lett (1993) 1.62
Cloning of the human IL-13R alpha1 chain and reconstitution with the IL4R alpha of a functional IL-4/IL-13 receptor complex. FEBS Lett (1997) 1.57
Acute childhood leukaemia and residence next to petrol stations and automotive repair garages: the ESCALE study (SFCE). Occup Environ Med (2009) 1.56
Day-care, early common infections and childhood acute leukaemia: a multicentre French case-control study. Br J Cancer (2002) 1.53
Purification and characterization of six cytochrome P-450 isozymes from human liver microsomes. Biochemistry (1983) 1.51
Incidence of childhood leukaemia in the vicinity of nuclear sites in France, 1990-1998. Br J Cancer (2004) 1.50
Primary structure and functional expression of mouse pituitary and human brain corticotrophin releasing factor receptors. FEBS Lett (1993) 1.48
Rat pleural mesothelial cells in culture. In Vitro (1981) 1.48
Management strategy of pulmonary nodule in 2013. Diagn Interv Imaging (2013) 1.47
Isolation and characterization of a new peroxiredoxin from poplar sieve tubes that uses either glutaredoxin or thioredoxin as a proton donor. Plant Physiol (2001) 1.46
Updating the H-antigen classification of Bacillus thuringiensis. J Appl Microbiol (1999) 1.44
Monitoring of azathioprine-induced immunosuppression with thiopurine methyltransferase activity in kidney transplant recipients. Transplantation (1995) 1.44
A multicentre, double-blind study comparing placebo, ondansetron and ondansetron plus dexamethasone for the control of cisplatin-induced delayed emesis. Ondansetron Delayed Emesis Study Group. Ann Oncol (1996) 1.44
Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor alpha chain. J Biol Chem (1996) 1.43
Incidence of childhood leukaemia and non-Hodgkin's lymphoma in France: National Registry of Childhood Leukaemia and Lymphoma, 1990-1999. Eur J Cancer Prev (2004) 1.43
Concurrent cisplatin/etoposide chemotherapy plus twice daily thoracic radiotherapy in limited stage small cell lung cancer: a phase II study. Lung Cancer (2000) 1.39
p53 alterations predict tumor response to neoadjuvant chemotherapy in head and neck squamous cell carcinoma: a prospective series. J Clin Oncol (2000) 1.39
Involvement of cytochrome P450 3A4 enzyme in the N-demethylation of methadone in human liver microsomes. Chem Res Toxicol (1996) 1.39
Morphometric study in chronic obstructive bronchopulmonary disease. Pathologic, clinical, and physiologic correlations. Am Rev Respir Dis (1969) 1.38
Topographic distribution of asbestos fibres in human lung in relation to occupational and non-occupational exposure. Inhaled Part (1975) 1.36
CFTR gene mutations in adults with disseminated bronchiectasis. Eur J Hum Genet (1997) 1.35
Human CYP2B6: expression, inducibility and catalytic activities. Pharmacogenetics (1999) 1.34
In vitro reactivity of alveolar macrophages and red blood cells with asbestos fibres treated with oxalic acid, sulfur dioxide and benzo-3,4-pyrene. Toxicology (1981) 1.34
Infectious diseases in the first year of life, perinatal characteristics and childhood acute leukaemia. Br J Cancer (2004) 1.33
Leaching of chrysotile asbestos in human lungs. Correlation with in vitro studies using rabbit alveolar macrophages. Environ Res (1977) 1.33
Retrospective survey of Chikungunya disease in Réunion Island hospital staff. Epidemiol Infect (2007) 1.32
Ciliary abnormalities in bronchial epithelium of smokers, ex-smokers, and nonsmokers. Am J Respir Crit Care Med (1995) 1.32
Features of asbestos-exposed and unexposed mesothelioma. Am J Ind Med (1982) 1.32
Phagocytosis of chrysotile fibers by pleural mesothelial cells in culture. Am J Pathol (1979) 1.30
[The heat wave in France in August 2003]. Rev Epidemiol Sante Publique (2004) 1.28
Regulation of the acetoin catabolic pathway is controlled by sigma L in Bacillus subtilis. J Bacteriol (2001) 1.27
Cyclosporine-induced endoplasmic reticulum stress triggers tubular phenotypic changes and death. Am J Transplant (2008) 1.26
Estimation of the past and future burden of mortality from mesothelioma in France. Occup Environ Med (1998) 1.26
Acute childhood leukaemia and environmental exposure to potential sources of benzene and other hydrocarbons; a case-control study. Occup Environ Med (2004) 1.25
Relevance of an intensive postoperative follow-up after surgery for non-small cell lung cancer. Ann Thorac Surg (2000) 1.23
Simultaneous detection and quantitation of Chikungunya, dengue and West Nile viruses by multiplex RT-PCR assays and dengue virus typing using high resolution melting. J Virol Methods (2009) 1.22
Asbestos bodies in bronchoalveolar lavage fluid and in lung parenchyma. Am Rev Respir Dis (1988) 1.22
Chromosomal changes induced by chrysotile fibres or benzo-3,4-pyrene in rat pleural mesothelial cells. Mutat Res (1986) 1.21
Culture procedure of mesothelial cells from the rat parietal pleura. Biomedicine (1978) 1.19
The effects of urapidil therapy on hemodynamics and gas exchange in exercising patients with chronic obstructive pulmonary disease and pulmonary hypertension. Am Rev Respir Dis (1988) 1.19
Determination of microsatellite instability, p53 and K-RAS mutations in hepatic metastases from patients with colorectal cancer: relationship with response to 5-fluorouracil and survival. Int J Cancer (2001) 1.18
In vitro biodegradation of chrysotile fibres by alveolar macrophages and mesothelial cells in culture: comparison with a pH effect. Br J Ind Med (1984) 1.17
Genetic polymorphisms and childhood acute lymphoblastic leukemia: GWAS of the ESCALE study (SFCE). Leukemia (2012) 1.16
The liver in alpha 1-antitrypsin deficiency. Digestion (1974) 1.16
Silica-associated connective tissue disease. A study of 24 cases. Medicine (Baltimore) (1995) 1.16
Inhibition by omeprazole of proguanil metabolism: mechanism of the interaction in vitro and prediction of in vivo results from the in vitro experiments. J Pharmacol Exp Ther (1997) 1.15
Construction and characterization of a bovine BAC library with four genome-equivalent coverage. Genet Sel Evol (2001) 1.14
Lung cancer in HIV infected patients: facts, questions and challenges. Thorax (2006) 1.13
The DegS/DegU and ComP/ComA two-component systems are part of a network controlling degradative enzyme synthesis and competence in Bacillus subtilis. Res Microbiol (1995) 1.12
Diagnosis of smear-negative pulmonary tuberculosis using sequence capture polymerase chain reaction. Am J Respir Crit Care Med (1997) 1.12
Risk of spontaneous abortion among nurses handling antineoplastic drugs. Scand J Work Environ Health (1990) 1.12
Microsomal cytochrome P450 2C5: comparison to microbial P450s and unique features. J Inorg Biochem (2000) 1.11
Immunoquantification of epoxide hydrolase and cytochrome P-450 isozymes in fetal and adult human liver microsomes. Eur J Biochem (1985) 1.11
New limits on the drift of fundamental constants from laboratory measurements. Phys Rev Lett (2004) 1.11
Cytochromes P-450 in human hepatocyte plasma membrane: recognition by several autoantibodies. Gastroenterology (1993) 1.11
Brain metastases at the time of presentation of non-small cell lung cancer: a multi-centric AERIO analysis of prognostic factors. Br J Cancer (2001) 1.10
Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug. Proc Natl Acad Sci U S A (1987) 1.10
Daily intravenous infusions of Corynebacterium parvum in twenty patients with disseminated cancer: a preliminary report of clinical and biologic findings. J Natl Cancer Inst (1975) 1.09
Sialic acids as important molecules in the regulation of the immune system: pathophysiological implications of sialidases in immunity. Glycobiology (1993) 1.09
Restoration of the jejunal mucosa in rats refed after prolonged fasting. Comp Biochem Physiol A Mol Integr Physiol (2001) 1.09
Quantitative study of parenchyma and small conductive airways in chronic nonspecific lung disease. Use of histologic stereology and bronchial casts. Chest (1972) 1.09
Retrospective evaluation of occupational exposures in population-based case-control studies: general overview with special attention to job exposure matrices. Int J Epidemiol (1993) 1.09
Identification of the cytochrome P450 IIIA family as the enzymes involved in the N-demethylation of tamoxifen in human liver microsomes. Biochem Pharmacol (1991) 1.09
Morphology of gill epithelia in fish. Am J Physiol (1980) 1.08
Microsomal P450 2C3 is expressed as a soluble dimer in Escherichia coli following modification of its N-terminus. Arch Biochem Biophys (1997) 1.08
Childhood leukaemia incidence around French nuclear installations using geographic zoning based on gaseous discharge dose estimates. Br J Cancer (2006) 1.08
Chemical and photoelectron spectrometry analysis of the adsorption of phospholipid model membranes and red blood cell membranes on to chrysotile fibres. Br J Ind Med (1980) 1.08
Cigarette smoke blocks cross-linking of elastin in vitro. Am Rev Respir Dis (1983) 1.07
Studying the performance of a job exposure matrix. Int J Epidemiol (1993) 1.06